Jennifer Herz talks about some of the development and manufacturing challenges that need to be overcome to produce a vaccine against COVID19. Whilst the progress in vaccine development is evolving daily through the pandemic, the key messages from this presentation remain the same. Australia needs to invest more to bridge the gap between early stage research and commercial scale manufacturing so we can secure a strategic place in the global supply chain.
Biointelect and CR2O forge new strategic partnership to provide advanced end-to-end commercialisation solutions for the life science sector globally
Driving more efficient and accelerated results from pre-clinical trials to
